{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Sheet1"],"read":"whole","date_system":"1900"}

{"sheet":"Sheet1","index":0,"n_rows":150,"n_cols":4,"rows_kept":150,"merged":[[0,0,0,3]]}
["血液病外送项目明细"]
["序号","项目名称","标准收费（元）","预计年测试数量(例)"]
[1,"*白血病中56融合基因筛查",2431,5]
[2,"*髓系白血病中常见融合基因筛查",884,20]
[3,"*淋系白血病中常见融合基因筛查",884,20]
[4,"*NK细胞穿孔素和颗粒酶检测(10CD)",500,5]
[5,"*骨髓组织活检评估套餐(1项特染+3项\n免疫组化)",649,5]
[6,"*骨髓组织活检评估套餐(1项特染+8项\n免疫组化)",1384,5]
[7,"*淋巴造血组织病理诊断套餐(病理诊断\n+15项免疫组化+EBER原位杂交)",2724,5]
[8,"*AML治疗靶点CD33/CLL1(CD371)/CD123\n\n流式检测(10CD)",500,5]
[9,"*多药耐药蛋白P-gp检测(5CD)",250,5]
[10,"*高敏PNH全套检测(14CD,含红/粒/单核 )",700,5]
[11,"融合基因分型(F1PIL1-PDGFRα）",221,10]
[12,"FISH检查单探针",1200,30]
[13,"PML/RAR a t(15;17)(q23;q21)",1200,5]
[14,"AML1/ETO t(8;21)(q22;q22)",1200,5]
[15,"CBFβ inv/t(16;16)(p13;q22)",1200,5]
[16,"EVI1基因重排",1200,5]
[17,"RARA基因重排",1200,5]
[18,"RPN1/EVI1 inv(3)",1200,5]
[19,"BCR/ABL1 t(9;22)(q34;q11)",1200,5]
[20,"5q-",1200,5]
[21,"7q-",1200,5]
[22,"-Y",1200,5]
[23,{"v":8,"d":"+8"},1200,5]
[24,"20q-",1200,5]
[25,"KMT2A-MLLT3融合基因",1200,5]
[26,"MLAA-34基因检测",1200,5]
[27,"MLL(11q23)基因重排",1200,5]
[28,"TEL/AML1 t(12;21)(p13;q22)",1200,5]
[29,"E2A(TCF3)基因重排",1200,5]
[30,"IGH基因重排14q32",1200,5]
[31,"JAK2基因重排",1200,5]
[32,"21号染色体内(iAMP21)基因扩增检测",1200,5]
[33,"MYC基因重排8q24",1200,5]
[34,"CRLF2基因重排",1200,5]
[35,"MEF2D基因重排",1200,5]
[36,"KMT2A-AFF1融合基因检测",1200,5]
[37,"E2A-PBX1融合基因检测",1200,5]
[38,"NUP98基因断裂检测",1200,5]
[39,"PDGFRa基因重排(4q12)",1200,5]
[40,"PDGFRβ基因重排(5q33.2)",1200,5]
[41,"FGFR1基因重排(8p12)",1200,5]
[42,"JAK2基因重排(9p24)",1200,5]
[43,"p53基因(17p13.1)缺失检测",1200,5]
[44,"RB1(13q14)基因缺失",1200,5]
[45,"ATM基因(11q22)缺失检测",1200,5]
[46,"CEP12",1200,5]
[47,"C-MYC基因扩增检测",1200,5]
[48,"IgH/CCND1(BCL1)t(11;14)(q13;q32)",1200,5]
[49,"IGH/CCND3融合基因",1200,5]
[50,"IGH/MAFB融合基因检测",1200,5]
[51,"IgH/FGFR3 t(4;14)(p16.3;q32.3)",1200,5]
[52,"IGH-MYEOV融合基因检测",1200,5]
[53,"CKS1B(1q21)基因扩增检测",1200,5]
[54,"IgH/BCL2 t(14;18)(q32;q21)",1200,5]
[55,"BCL2基因重排检测",1200,5]
[56,"IgH/MYC融合基因检测，\nt(8;14)(q24;q32)",1200,5]
[57,"IRF4基因重排6p25",1200,5]
[58,"BCL6基因重排检测，3q27",1200,5]
[59,"IGH/MALT1,t(14;18)",1200,5]
[60,"6g缺失检测",1200,5]
[61,"IGH/PAX5融合基因检测",1200,5]
[62,"IGH/FOXP1融合基因检测",1200,5]
[63,"IGH/BCL10融合基因检测",1200,5]
[64,"MALT1基因重排检测",1200,5]
[65,"CCND1重排基因检测",1200,5]
[66,"CCND2重排基因检测",1200,5]
[67,"TP63重排基因检测",1200,5]
[68,"E2A/HLF(TCF3/HLF)融合基因",2400,5]
[69,"BCR/ABL1,ASSI",2400,5]
[70,"ALK基因重排检测，2p23",2400,5]
[71,"MALT1/API2融合基因检测，t(11;18)",2400,5]
[72,"白血病中30融合基因筛查",1547,5]
[73,"白血病中43融合基因筛查",1989,5]
[74,"融合基因PML/RAR α分型定性",221,5]
[75,"PML-RAR a融合基因bcr-1(L型)定量",221,5]
[76,"PML-RAR α融合基因bcr-2(V型)定量",221,5]
[77,"PML-RAR  α融合基因bcr-3(S型)定量",221,5]
[78,"PML-RARA融合基因分型&定量(初诊)",442,5]
[79,"融合基因检测（PCR）",442,50]
[80,"CBF β/MYH11定量检测",221,5]
[81,"AML1/ETO定量",221,5]
[82,"DEK-NUP214融合基因定量检测",221,5]
[83,"MLL/AF10(KMT2A/MLLT10)定量检测",221,5]
[84,"MLL-AF6(KMT2A-MLLT4)融合基因定量检测",221,5]
[85,"MLL/AF9融合基因定量检测",221,5]
[86,"BCR/ABL1融合基因分型定量",442,5]
[87,"JAK2基因V617F突变检测",442,50]
[88,"BCR-ABL1(p190)融合基因定量检测",221,60]
[89,"BCR-ABL1融合基因分型(定性)",221,20]
[90,"SIL-TAL1融合基因定量检测",221,5]
[91,"MLL-ENL(KMT2A-MLLT1)定量检测",442,5]
[92,"MLL-AF4融合基因定量检测",221,5]
[93,"E2A-PBX1融合基因定量检测",221,5]
[94,"TEL-AML1融合基因定量检测",221,5]
[95,"TEL-ABL1基因重排检测",221,5]
[96,"TEL-PDGFRB(ETV6-PDGFRB)融合基因定量",221,10]
[97,"FIP1L1-PDGFRa融合基因定量检测",221,10]
[98,"伊马替尼",70,10]
[99,"尿免疫固定电泳(IgA、IgG、IgM)",242,10]
[100,"骨髓移植性染色体错配    (CEPX/CEPY)",1200,10]
[101,"群体反应性抗体(Panel reactive\nantibody)PRA,定性",391,10]
[102,"大B细胞淋巴瘤IGH/BCL2,BCL-6、MYC重排",3600,10]
[103,"骨髓涂片检查",85,10]
[104,"骨髓组织活检检查与诊断",135,10]
[105,"淋巴造血组织病理诊断套餐(病理诊断\n+10项免疫组化)",1807,10]
[106,"淋巴造血组织病理套餐(病理诊断+20项\n免疫组化)",3277,10]
[107,"急慢性白血病/NHL/MDS全面CD系列检测\n(40 CD)",2000,20]
[108,"白血病CD系列检测(28CD)",1400,80]
[109,"急性白血病快速鉴别诊断CD系列检测\n(15 CD)",750,10]
[110,"微小残留白血病检测(28CD)",1400,10]
[111,"微小残留白血病检测(15CD)",750,50]
[112,"神经母细胞瘤/ALL鉴别相关CD检测\n(15CD)",750,5]
[113,"神经母细胞瘤MRD检测(5CD)",250,5]
[114,"MDS相关CD系列检测(25CD)",1250,30]
[115,"MDS相关CD系列检测(15CD)",750,30]
[116,"MDS/AA鉴别相关CD系列检测(15CD)",750,20]
[117,"淋巴瘤/淋系白血病相关CD系列检测\n(25CD)",1250,20]
[118,"淋巴瘤/淋系白血病相关CD系列检测\n(15CD)",750,20]
[119,"外周血淋巴细胞增多快速鉴别诊断CD系\n列检测(15CD)",750,5]
[120,"浆细胞肿瘤相关CD系列检测(15CD)",750,50]
[121,"多发性骨髓瘤(MM)微小残留(15CD)",750,20]
[122,"毛细胞白血病(HCL)相关CD系列检测\n(15CD)",750,5]
[123,"NK细胞淋巴瘤/白血病相关抗原检测\n(25CD)",1250,5]
[124,"B-CLL MRD检测(15CD)",750,5]
[125,"ZAP-70检查(15CD,包含CD38),流式细胞术",750,5]
[126,"ZAP-70检测(8CD,不含CD38),流式细胞术",400,5]
[127,"自身免疫性血细胞减少相关抗原检测",750,5]
[128,"骨髓染色体核型分析(肿瘤)",333,250]
[129,"外周血染色体核型分析(血液肿瘤)",283,20]
[130,"尿免疫球蛋白轻链定量",50,5]
[131,"血小板无力症/巨大血小板检测(3CD)",150,5]
[132,"CD34+细胞百分含量检测(3CD)",150,5]
[133,"CD34+细胞绝对计数",200,5]
[134,"HLA高分辨配型 HLA-A/B/C/DRB1/DQB1(5个位点)",1630,5]
[135,"溶贫六项",33,5]
[136,"溶贫七项",36,5]
[137,"促红细胞生成素(EPO)",25,5]
[138,"红细胞孵育渗透脆性试验+G6PD缺陷筛查",12,5]
[139,"葡萄糖6-磷酸脱氢酶(G-6-PD)缺陷筛查",10,5]
[140,"红细胞孵育渗透脆性试验(MDST)",2,5]
[141,"直接抗人球蛋白试验(IgG+C3d型)",5,5]
[142,"间接抗人球蛋白试验",5,5]
[143,"遗传球初筛检测2项",4,5]
[144,"粒细胞CD55、CD59评估",150,5]
[145,"红细胞CD55、CD59评估",100,5]
[146,"高敏PNH白细胞检测(10CD)",500,5]
[147,"BCR-ABL1(p210)融合基因定量检测",221,100]
[148,"BCR-ABL1(p230)融合基因定量检测",221,60]